128 related articles for article (PubMed ID: 2996123)
1. Myeloperoxidase-deficient polymorphonuclear leucocytes. (V): Relation to FAB-classification and neutrophil alkaline phosphatase activity in primary myelodysplastic syndromes.
Bendix-Hansen K; Kerndrup G
Scand J Haematol; 1985 Aug; 35(2):197-200. PubMed ID: 2996123
[TBL] [Abstract][Full Text] [Related]
2. Myeloperoxidase-deficient polymorphonuclear leucocytes (VI): Relation to cytogenetic abnormalities in primary myelodysplastic syndromes.
Bendix-Hansen K; Kerndrup G; Pedersen B
Scand J Haematol; 1986 Jan; 36(1):3-7. PubMed ID: 3006222
[TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase-deficient polymorphonuclear leucocytes (VII): Incidence in untreated myeloproliferative disorders.
Bendix-Hansen K
Scand J Haematol; 1986 Jan; 36(1):8-10. PubMed ID: 3006224
[TBL] [Abstract][Full Text] [Related]
4. Myeloperoxidase-deficient polymorphonuclear leucocytes. Longitudinal study during the preremission--and the remission phase in acute myeloid leukaemia. Comparison to neutrophil alkaline phosphatase (NAP) activity.
Bendix-Hansen K
Blut; 1986 Apr; 52(4):237-42. PubMed ID: 3008894
[TBL] [Abstract][Full Text] [Related]
5. A study of the haematologic spectrum of myelodysplastic syndrome.
Kini J; Khadilkar UN; Dayal JP
Indian J Pathol Microbiol; 2001 Jan; 44(1):9-12. PubMed ID: 12561987
[TBL] [Abstract][Full Text] [Related]
6. Myeloperoxidase-deficient polymorphonuclear leucocytes. (IV): Relation to FAB-classification in acute myeloid leukaemia.
Bendix-Hansen K; Nielsen HK
Scand J Haematol; 1985 Aug; 35(2):174-7. PubMed ID: 2996122
[TBL] [Abstract][Full Text] [Related]
7. Myeloperoxidase-deficient polymorphonuclear leucocytes. (I) Incidence in untreated myeloid leukaemia, lymphoid leukaemia and normal humans.
Bendix-Hansen K; Kaspersen Nielsen H
Scand J Haematol; 1983 May; 30(5):415-9. PubMed ID: 6304866
[TBL] [Abstract][Full Text] [Related]
8. [Retrospective analysis of hemotherapy support in 226 cases of myelodysplastic syndromes].
Rubio-Félix D; Franco E; Giraldo P; Gimeno J; Cuesta I; Giralt M
Sangre (Barc); 1994 Apr; 39(2):117-20. PubMed ID: 8059289
[TBL] [Abstract][Full Text] [Related]
9. Absent or extremely low neutrophil alkaline phosphatase activity levels in patients with myelodysplastic syndromes.
Yoshida Y; Katsurada T; Oguma S; Nakabo Y; Yoshinaga N; Kawahara M; Kawabata H
Intern Med; 2013; 52(4):479-82. PubMed ID: 23411705
[TBL] [Abstract][Full Text] [Related]
10. Myelodysplastic syndromes: analysis of clinical and prognostic features in 96 patients.
van der Weide M; Sizoo W; Nauta JJ; Krefft J; Langenhuijsen MM
Eur J Haematol; 1988 Aug; 41(2):115-22. PubMed ID: 3165865
[TBL] [Abstract][Full Text] [Related]
11. Myeloperoxidase deficient polymorphonuclear leucocytes in leukaemia and allied disorders.
Bendix-Hansen K
Dan Med Bull; 1988 Dec; 35(6):501-20. PubMed ID: 2851415
[TBL] [Abstract][Full Text] [Related]
12. Myeloperoxidase-deficient polymorphonuclear leucocytes (III): Relation to incidence of infection in acute myeloid leukaemia.
Nielsen HK; Bendix-Hansen K
Scand J Haematol; 1984 Jul; 33(1):75-9. PubMed ID: 6087443
[TBL] [Abstract][Full Text] [Related]
13. Myelodysplastic syndromes: analysis of morphological features related to the FAB-classification.
van der Weide M; Sizoo W; Krefft J; Langenhuijsen MM
Eur J Haematol; 1988 Jul; 41(1):58-61. PubMed ID: 2456946
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Features in the Myelodysplastic Syndromes: Importance of Morphological Atypia in the Marrow Cell Lineages.
Takahashi M; Koike T; Kishi K; Moriyama Y; Hayashi S; Shibata A
Leuk Lymphoma; 1990; 1(2):141-6. PubMed ID: 27463820
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic syndromes: analysis of 131 cases according to the FAB classification.
Economopoulos T; Stathakis N; Foudoulakis A; Papadoulis N; Dervenoulas J; Papageorgiou E; Anastassiou C; Hadjioannou J; Raptis S
Eur J Haematol; 1987 Apr; 38(4):338-44. PubMed ID: 3609254
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of c-myc p67 oncoprotein in patients with myelodysplastic syndromes in transformation to acute leukaemia.
Kyriakou D; Eliopoulos AG; Alexandrakis M; Kalokyri I; Eliopoulos GD
Haematologia (Budap); 1996; 28(1):1-7. PubMed ID: 9283897
[TBL] [Abstract][Full Text] [Related]
17. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.
Aul C; Gattermann N; Heyll A; Germing U; Derigs G; Schneider W
Leukemia; 1992 Jan; 6(1):52-9. PubMed ID: 1736014
[TBL] [Abstract][Full Text] [Related]
18. Myelodysplastic syndromes: a study of 101 cases according to the FAB classification.
Vallespi T; Torrabadella M; Julia A; Irriguible D; Jaen A; Acebedo G; Triginer J
Br J Haematol; 1985 Sep; 61(1):83-92. PubMed ID: 3863667
[TBL] [Abstract][Full Text] [Related]
19. Complement receptor type 1 (CR1) deficiency on neutrophils in myelodysplastic syndrome.
Ohsaka A; Saionji K; Watanabe N; Yokomichi H; Sugahara Y; Nagayama R; Igari J
Br J Haematol; 1994 Oct; 88(2):409-12. PubMed ID: 7803293
[TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of serum thymidine kinase in primary myelodysplastic syndromes: relationship to development of acute myeloid leukaemia.
Musto P; Bodenizza C; Falcone A; D'Arena G; Scalzulli P; Perla G; Modoni S; Parlatore L; Valvano MR; Carotenuto M
Br J Haematol; 1995 May; 90(1):125-30. PubMed ID: 7786774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
